Your browser is no longer supported. Please, upgrade your browser.
Settings
RGEN Repligen Corporation daily Stock Chart
RGEN [NASD]
Repligen Corporation
Index- P/E102.63 EPS (ttm)0.34 Insider Own0.70% Shs Outstand33.91M Perf Week3.05%
Market Cap1.19B Forward P/E47.24 EPS next Y0.74 Insider Trans-9.75% Shs Float33.43M Perf Month11.39%
Income11.70M PEG4.11 EPS next Q0.13 Inst Own98.70% Short Float10.62% Perf Quarter9.48%
Sales104.50M P/S11.39 EPS this Y23.10% Inst Trans1.46% Short Ratio15.72 Perf Half Y10.69%
Book/sh4.99 P/B7.03 EPS next Y34.36% ROA4.70% Target Price35.75 Perf Year31.12%
Cash/sh4.18 P/C8.40 EPS next 5Y25.00% ROE7.40% 52W Range21.11 - 35.61 Perf YTD13.89%
Dividend- P/FCF371.95 EPS past 5Y53.60% ROI6.00% 52W High-1.77% Beta1.41
Dividend %- Quick Ratio7.60 Sales past 5Y34.80% Gross Margin54.90% 52W Low65.70% ATR1.04
Employees236 Current Ratio8.70 Sales Q/Q19.60% Oper. Margin15.30% RSI (14)68.22 Volatility3.31% 2.92%
OptionableYes Debt/Eq0.56 EPS Q/Q1798.10% Profit Margin11.20% Rel Volume0.81 Prev Close35.10
ShortableYes LT Debt/Eq0.56 EarningsFeb 22 BMO Payout0.00% Avg Volume225.86K Price34.98
Recom1.80 SMA204.98% SMA5010.97% SMA20015.09% Volume29,514 Change-0.34%
Feb-13-17Upgrade Piper Jaffray Neutral → Overweight
Feb-22-16Initiated Craig Hallum Buy
Nov-06-15Downgrade Jefferies Buy → Hold
Apr-23-15Reiterated Jefferies Buy $25 → $38
Mar-07-11Downgrade Rodman & Renshaw Mkt Outperform → Mkt Perform
Jun-30-09Initiated Merriman Buy
Jun-12-08Reiterated Rodman & Renshaw Mkt Outperform $11 → $9
Sep-10-07Reiterated Rodman & Renshaw Mkt Outperform $6 → $8
Apr-12-07Reiterated Rodman & Renshaw Mkt Outperform $5 → $6
Mar-17-17 03:06PM  Stocks Flat But Alphabet, Lockheed Martin Hit New Highs
Mar-01-17 04:03PM  REPLIGEN CORP Files SEC form 8-K/A, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhi
01:04PM  REPLIGEN CORP Financials
08:00AM  Top 3 Healthcare Penny Stocks for 2017 at Investopedia
Feb-23-17 12:35PM  Repligen Corp. :RGEN-US: Earnings Analysis: 2016 By the Numbers : February 23, 2017
10:24AM  Repligen Corp. :RGEN-US: Earnings Analysis: Q4, 2016 By the Numbers : February 23, 2017
Feb-22-17 04:31PM  Edited Transcript of RGEN earnings conference call or presentation 22-Feb-17 1:30pm GMT +6.04%
07:55AM  Repligen beats 4Q profit forecasts
07:40AM  REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:30AM  Repligen Reports Fourth Quarter 2016 Financial Results, Provides Guidance for 2017 GlobeNewswire
Feb-21-17 07:12AM  Repligen Corp. breached its 50 day moving average in a Bullish Manner : RGEN-US : February 21, 2017
Feb-16-17 05:02PM  Repligen To Report Fourth Quarter and Full Year 2016 Financial Results, Provides Financial Guidance for 2017 GlobeNewswire
Feb-13-17 06:37AM  Repligen upgraded by Piper Jaffray
Jan-04-17 09:30AM  The Zacks Analyst Blog Highlights: Sucampo Pharmaceuticals, Dr. Reddy's Laboratories, BioMarin Pharmaceutical and Repligen
07:30AM  Repligen to Present at 35th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Jan-03-17 10:48AM  Repligen Corp. Value Analysis (NASDAQ:RGEN) : January 3, 2017
08:32AM  3 Overlooked Drug Stocks to Watch Out for in 2017
Jan-02-17 08:14AM  Repligen Corp. breached its 50 day moving average in a Bearish Manner : RGEN-US : January 2, 2017
Dec-16-16 08:15AM  Blog Coverage Repligen Acquires Maker of Tangential Flow Filtration Cassettes Accesswire
Dec-15-16 05:20PM  REPLIGEN CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Dispositio
08:30AM  Novasep Sells U.S. Subsidiary TangenX Technology Corporation, Innovator in Tangential Flow Filtration for Biopharmaceuticals PR Newswire
07:41AM  UPDATE -- Repligen Acquires TangenX Technology Corporation GlobeNewswire
06:58AM  Repligen Acquires TangenX Technology Corporation GlobeNewswire
Dec-10-16 06:46PM  Is Repligen Corporation (RGEN) a Good Stock to Buy? at Insider Monkey
Nov-11-16 07:07AM  Repligen Corp. breached its 50 day moving average in a Bullish Manner : RGEN-US : November 11, 2016
Nov-10-16 03:00PM  5 Health Care Stocks Set to Bounce
Nov-07-16 11:27AM  Repligen to Participate in Stephens Inc. Fall Investment Conference 2016 GlobeNewswire
Nov-03-16 02:51PM  Edited Transcript of RGEN earnings conference call or presentation 3-Nov-16 12:30pm GMT -5.67%
12:26PM  3 Important Things You Need to Know About Repligen Corporation's Q3 Results at Motley Fool
08:01AM  REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:44AM  Repligen meets 3Q profit forecasts
07:30AM  Repligen Reports Third Quarter 2016 Financial Results GlobeNewswire
07:07AM  Q3 2016 Repligen Corp Earnings Release - Before Market Open
Nov-01-16 10:26AM  3 Top Stocks for Risk-Averse Investors at Motley Fool
Oct-20-16 07:30AM  Repligen to Report Third Quarter 2016 Financial Results GlobeNewswire
Oct-18-16 07:30AM  Repligen Hires Ralf Kuriyel as Senior Vice President of Research & Development GlobeNewswire
Oct-13-16 10:48AM  Bedford's Ocular Therapeutix inks potential $315M deal with Regeneron at bizjournals.com
Oct-11-16 08:16AM  Repligen Corp. breached its 50 day moving average in a Bullish Manner : RGEN-US : October 11, 2016
Oct-05-16 08:00AM  Repligen Launches Single-Use XCell ATF System for Bioprocess Intensification GlobeNewswire
Oct-04-16 10:19AM  ETFs with exposure to Repligen Corp. : October 4, 2016
Oct-03-16 12:29PM  Repligen Corp. Value Analysis (NASDAQ:RGEN) : October 3, 2016
Sep-30-16 08:27AM  Repligen Corp. breached its 50 day moving average in a Bearish Manner : RGEN-US : September 30, 2016
Sep-13-16 04:05PM  Repligen Has More Upside Ahead
Sep-02-16 04:17PM  REPLIGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Sep-01-16 07:30AM  Repligen to Present at Baird Global Healthcare Conference 2016 GlobeNewswire
Aug-23-16 05:07PM  These 3 Stocks Are Up Over 700% in the Last 5 Years at Motley Fool
Aug-09-16 12:07PM  Repligen Corp. :RGEN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016
Aug-04-16 04:39PM  Edited Transcript of RGEN earnings conference call or presentation 4-Aug-16 12:30pm GMT
09:59AM  Repligen beats Street 2Q forecasts
07:52AM  REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:30AM  Repligen Reports Second Quarter 2016 Financial Results GlobeNewswire
07:07AM  Q2 2016 Repligen Corp Earnings Release - Before Market Open
Jul-27-16 07:30AM  Repligen to Report Second Quarter 2016 Financial Results GlobeNewswire
Jul-01-16 05:23PM  Repligen Corp. Value Analysis (NASDAQ:RGEN) : July 1, 2016
Jun-30-16 08:45AM  Repligen (RGEN) in Focus: Stock Adds 6.9% in Session
08:17AM  Repligen Corp. breached its 50 day moving average in a Bullish Manner : RGEN-US : June 30, 2016
Jun-02-16 07:30AM  Repligen to Present at Jefferies 2016 Healthcare Conference GlobeNewswire
May-31-16 08:32AM  How to Invest in the Life Cycle of a Drug at Motley Fool
May-26-16 02:52PM  Repligen to Participate in 13th Annual Craig-Hallum Institutional Investor Conference GlobeNewswire
08:20AM  3 Stocks That Help Drugmakers Create Billion Dollar Blockbusters at Motley Fool
May-24-16 04:16PM  REPLIGEN CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
May-20-16 04:05PM  REPLIGEN CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and
May-19-16 08:41AM  Repligen Announces Pricing of $100 Million of 2.125% Convertible Senior Notes due 2021 GlobeNewswire -8.52%
May-18-16 04:20PM  Repligen Announces Proposed Public Offering of $100 Million of Convertible Senior Notes due 2021 GlobeNewswire
May-12-16 05:18PM  REPLIGEN CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Submission of Matters to a Vote of Secu
May-10-16 12:48PM  Repligen Corp. :RGEN-US: Earnings Analysis: Q1, 2016 By the Numbers
May-05-16 05:13PM  Edited Transcript of RGEN earnings conference call or presentation 5-May-16 12:30pm GMT
03:37PM  Repligen tops 1Q revenue forecasts
08:56AM  Repligen Corp. breached its 50 day moving average in a Bearish Manner : RGEN-US : May 5, 2016
07:50AM  REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:30AM  Repligen Reports First Quarter 2016 Financial Results GlobeNewswire
07:07AM  Q1 2016 Repligen Corp Earnings Release - Before Market Open
Apr-29-16 04:51PM  REPLIGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
11:24AM  Repligen to Report First Quarter 2016 Financial Results GlobeNewswire
08:26AM  The Biggest Threat to Repligen Stock at Motley Fool
Apr-04-16 04:09PM  Read This Before You Sell Repligen Corporation Stock at Motley Fool
07:44AM  REPLIGEN CORP Files SEC form 8-K, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Other Events, Fin
07:30AM  Repligen Acquires Atoll GmbH GlobeNewswire
Mar-31-16 08:46AM  Repligen Forms Scientific Advisory Board GlobeNewswire
Mar-21-16 08:19AM  Repligen Corp. breached its 50 day moving average in a Bearish Manner : RGEN-US : March 21, 2016
Mar-10-16 01:55PM  ETFs with exposure to Repligen Corp. : March 10, 2016
Mar-07-16 12:54PM  Repligen Corp. :RGEN-US: Earnings Analysis: Q4, 2015 By the Numbers
Mar-06-16 10:07AM  Repligen Corporation Jumped 14.6% in February -- Here's Why at Motley Fool
Feb-25-16 01:42PM  Edited Transcript of RGEN earnings conference call or presentation 25-Feb-16 1:30pm GMT
08:05AM  Repligen tops 4Q revenue forecasts
08:02AM  REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:30AM  Repligen Reports Fourth Quarter and Year 2015 Financial Results GlobeNewswire
07:07AM  Q4 2015 Repligen Corp Earnings Release - Before Market Open
Feb-24-16 05:19PM  REPLIGEN CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Sta
04:59PM  Repligen Announces Extension of Long Term Supply Agreement for Protein A GlobeNewswire
Feb-23-16 03:00PM  Cabillys last stand: The newest challenge to biotechs biggest patent at bizjournals.com
08:22AM  Repligen Corp. breached its 50 day moving average in a Bullish Manner : February 23, 2016
Feb-17-16 07:30AM  Repligen to Report Fourth Quarter and Full Year 2015 Financial Results GlobeNewswire
Jan-20-16 04:59PM  8 Stocks Moving In Wednesday's After-Hours Session +12.38%
Dec-30-15 04:41PM  Why These Four Stocks Are Moving In Wednesday's After-Hours Session
Dec-29-15 09:03AM  Why You Shouldn't Bet Against Repligen (RGEN) Stock
Dec-21-15 09:26AM  Repligen Corp. breached its 50 day moving average in a Bullish Manner : December 21, 2015
Dec-16-15 10:04AM  Repligen Corp. Value Analysis (NASDAQ:RGEN) : December 16, 2015
Dec-15-15 01:01PM  Repligen Corp. Earnings Analysis: Q3, 2015 By the Numbers
Dec-14-15 02:53PM  Here are the 20 top-performing stocks in Mass. for 2015 at bizjournals.com
Repligen Corporation, a bioprocessing company, focuses on the development, production, and commercialization of products used in the production of antibody-based therapeutics, recombinant proteins, and vaccines worldwide. It manufactures various forms of Protein A, a critical component used to purify antibody-based drugs. The company also supplies alternating tangential flow system filtration devices and protein cell culture supplements that are used in clinical and commercial stage manufacturing to enhance biologic drug yields. In addition, it manufactures and sells OPUS pre-packed chromatography columns, which are used in the purification of clinical-stage biologics; and tangential flow filtration cassettes that are used to concentrate clinical and commercial stage biologic drugs. Further, the company has a portfolio of therapeutic product candidates, which include histone deacetylase inhibitor for the treatment of Friedreich's ataxia disease; and RG1068, a synthetic human hormone developed as a novel imaging agent for the detection of pancreatic duct abnormalities in combination with magnetic resonance imaging in patients with pancreatitis and other pancreatic diseases. The company sells its bioprocessing products directly and through distributors to various life sciences companies, biopharmaceutical companies, and contract manufacturers. Repligen Corporation was founded in 1981 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DAWES KAREN ADirectorMar 21Option Exercise4.2920,00085,80095,764Mar 22 05:20 PM
DAWES KAREN ADirectorMar 21Sale34.122,52186,01793,243Mar 22 05:20 PM
RYAN THOMAS F JRDirectorMar 20Option Exercise3.224,00012,88012,594Mar 22 04:34 PM
Benjamin HowardVP Business DevelopmentMar 20Option Exercise9.4414,968141,34136,124Mar 22 04:41 PM
Benjamin HowardVP Business DevelopmentMar 20Sale34.6212,216422,95423,908Mar 22 04:41 PM
RYAN THOMAS F JRDirectorMar 20Sale34.834,000139,3218,594Mar 22 04:34 PM
Snodgres JonChief Financial OfficerMar 17Option Exercise24.504,00098,00027,789Mar 21 09:03 PM
Snodgres JonChief Financial OfficerMar 17Sale34.911,90966,64623,789Mar 21 09:03 PM
Hunt AnthonyChief Executive OfficerNov 28Sale33.125,000165,61368,342Nov 29 04:58 PM
RYAN THOMAS F JRDirectorSep 14Sale32.582,70087,9799,394Sep 16 01:20 PM
RYAN THOMAS F JRDirectorJun 30Sale26.605,000133,01012,094Jul 01 04:06 PM
RYAN THOMAS F JRDirectorJun 28Option Exercise3.225,00016,10027,094Jun 29 02:46 PM
RYAN THOMAS F JRDirectorJun 28Sale24.5910,000245,88817,094Jun 29 02:46 PM
DAWES KAREN ADirectorJun 27Option Exercise3.1015,00046,50057,746Jun 28 04:40 PM
Benjamin HowardVP Business DevelopmentMay 24Option Exercise6.2310,00062,30028,626May 26 03:31 PM
Benjamin HowardVP Business DevelopmentMay 11Sale26.722,88977,19918,626May 13 03:32 PM